or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    STLA C -0.06 2.29
    HAFN D -2.26 1.77
    NVS F -0.55 1.59

    Represented by ETF Holdings

    Keywords: Active Pharmaceutical Ingredients Animal Health Antibiotics Automotive Manufacturers Biotechnology Blood Test Cars Chrysler Contact Lens Contact Lenses Diagnostic Products Disposable Product Disposable Products Drugs Eye Eye Care Eye Care Products Eyewear Fiat Fiat Chrysler Automobiles
    Industries: Auto Manufacturers Drug Manufacturers - Major

    Recent News for AAM S&P Developed Markets High Dividend Value ETF & its Holdings

    Date Stock Title
    Apr 18 STLA Sales Of Jeep, Stellantis' Crown Jewel, Have Slumped, Posing Added Risk To The Stock
    Apr 18 STLA New Dodge Complete Performance Vehicle Protection Package to Include Radford Racing School High-performance Driving Session
    Apr 18 NVS Exploring Analyst Estimates for Novartis (NVS) Q1 Earnings, Beyond Revenue and EPS
    Apr 17 NVS 2 High-Yield Dividend Stocks to Buy and Hold for 10 Years
    Apr 17 STLA Italian carmaker Alfa Romeo forced to rename ‘Italian sounding’ Milano model as right-wing government threatens carmaker with lawsuit weeks after trying to woo BYD
    Apr 17 NVS Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
    Apr 16 STLA Why you can't find China's cheap EVs in the US
    Apr 16 STLA Stellantis declares $1.651 dividend
    Apr 16 STLA Stellantis shareholders approve CEO Tavares' 2023 pay package
    Apr 16 NVS Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug
    Apr 16 STLA Stellantis NV (STLA) Reported Revenue Ahead of Consensus
    Apr 16 STLA Alfa Romeo rebrands Milano car after Meloni backlash
    Apr 16 STLA 12 Ridiculously Cheap Stocks to Buy Now and Hold for the Long Term
    Apr 15 STLA Stellantis (STLA) Rises As Market Takes a Dip: Key Facts
    Apr 15 STLA Jetsons-like travel in air taxis is 'as close as we've seen,' Joby's chief product officer says
    Apr 15 NVS New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
    Apr 15 STLA 10 Best Low Volatility ETFs To Buy
    Apr 15 NVS Antitrust fervor is gripping Washington and Silicon Valley. But lawsuits have been declining.
    Apr 12 NVS Novartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
    Apr 12 STLA The Expansion Of China's EV Makers Could Threaten The Legacy Of European Automakers
    The investment seeks to track the total return performance, before fees and expenses, of the S&P Developed Ex-U.S. Dividend and Free Cash Flow Yield Index. Under normal circumstances, at least 80% of the fund's total assets (exclusive of any collateral held from securities lending) will be invested in the component securities of the index and depositary receipts representing index components. The index is designed to provide exposure to the constituents of the S&P Developed BMI Ex-U.S. & Korea LargeMidcap Index that exhibit both high dividend yield and sustainable dividend distribution characteristics, while maintaining diversified sector exposure.
    Exchange Traded Fund ETF Dividend Yield Midcap Free Cash Flow S&P Developed
    Back to the Main DMDV Page...